Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The injectable version may be prescribed for people who need higher doses or faster results
Retatrutide (Retara), a triple GIP/GLP-1/glucagon agonist, produced the highest mean weight loss in clinical trials (24.2% at 48 weeks)
Rybelsus should not be used if you: You have a personal or family history of medullary thyroid carcinoma (MTC)
The best GLP-1 injection site for weight loss guide addresses whether injection location affects outcomes
Santana-Gutirrez A, Bautista-Gmez AJ, Gonzlez-Guajardo JA, Rosales-Sols GM, Ocampo-Candiani J, Muoz-Garza FZ
In a clinical setting, it is delivered through a once-weekly subcutaneous injection
US$ 27.20
US$ 23.24
US$ 21.36
US$ 23.97
US$ 25.45
US$ 28.34
